Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Vistakon, Johnson & Johnson Vision Products, Inc.

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Vistakon, Johnson & Johnson Vision Products, Inc.

Regulatory records
3
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 3 FDA records to the applicant name Vistakon, Johnson & Johnson Vision Products, Inc.. 3 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Dec 16, 2025 to Apr 17, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code LPM appears in 3 of the 3 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

Applicant mailing address recorded by FDA: 7500 Centurion Pkwy., Jacksonville, FL, 32256. Recorded on N18033/S114, decision dated Apr 17, 2026.

Changes described in PMA records

N18033/S114: VISTAKON (etafilcon A) Brand Contact Lenses

FDA’s recorded scope: addition of an alternate raw supplier for subcomponent, Reactive Blue No. 4 (RB4), used in the production of Vistakon (senofilcon A) and Vistakon (etafilcon A) Brand Contact Lenses at the Jacksonville, Florida and Limerick, Ireland manufacturing facilities

Apr 17, 2026 · 30-Day Notice

N18033/S113: VISTAKON (etafilcon A) lenses

FDA’s recorded scope: implementation of Cooper Tungsten (CuW) heat seal die plates for the production of Vistakon (etafilcon A) Brand Contact Lenses on Line 30 at the Limerick, Ireland manufacturing facility

Mar 10, 2026 · 30-Day Notice

N18033/S112: ACUVUE CONTACT LENS

FDA’s recorded scope: an update to the control plan for material characteristics for the Vistakon (senofilcon A) and (etafilcon A) Brand Contact Lenses

Dec 16, 2025 · 30-Day Notice

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Regulatory record history

Product / regulatory recordCompanyPathwayDecision dateSource
Vistakon, Johnson & Johnson Vision Products, Inc.PMA supplementApr 17, 2026FDA
Vistakon, Johnson & Johnson Vision Products, Inc.PMA supplementMar 10, 2026FDA
Vistakon, Johnson & Johnson Vision Products, Inc.PMA supplementDec 16, 2025FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.